Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lansing Taylor

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2018
A Quantitative Systems Pharmacology Approach to Infer Pathways Involved in Complex Disease PhenotypesMark E Schurdak, Fen Pei, Timothy R Lezon, et al.
Lab on a Chip|March 27, 2020
Applications of the microphysiology systems database for experimental ADME-Tox and disease modelsMark Schurdak, Lawrence Vernetti, Luke Bergenthal, et al.
Seminars in Liver Disease|July 4, 2025
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A PerspectiveMark T Miedel, Mark E Schurdak, Andrew M Stern, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 24, 2017
Biologically Relevant Heterogeneity: Metrics and Practical InsightsAlbert Gough, Andrew M Stern, John Maier, et al.
BMC Biotechnology|May 1, 2026
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2016
Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) PathwaysCemal Erdem, Alison M Nagle, Angelo J Casa, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 15, 2017
Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systemsFelipe T Lee-Montiel, Subin M George, Albert H Gough, et al.
Lab on a Chip|September 28, 2023
Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip systemVinny Negi, Dillon Gavlock, Mark T Miedel, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2026
Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platformDillon C Gavlock, Michael W Castiglione, Allen Wang, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2018
A Quantitative Systems Pharmacology Approach to Infer Pathways Involved in Complex Disease PhenotypesMark E Schurdak, Fen Pei, Timothy R Lezon, et al.
Lab on a Chip|March 27, 2020
Applications of the microphysiology systems database for experimental ADME-Tox and disease modelsMark Schurdak, Lawrence Vernetti, Luke Bergenthal, et al.
Seminars in Liver Disease|July 4, 2025
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A PerspectiveMark T Miedel, Mark E Schurdak, Andrew M Stern, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 24, 2017
Biologically Relevant Heterogeneity: Metrics and Practical InsightsAlbert Gough, Andrew M Stern, John Maier, et al.
BMC Biotechnology|May 1, 2026
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2016
Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) PathwaysCemal Erdem, Alison M Nagle, Angelo J Casa, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionJulio Aleman, Lawrence Vernetti, Mark E Schurdak, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 15, 2017
Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systemsFelipe T Lee-Montiel, Subin M George, Albert H Gough, et al.
Lab on a Chip|September 28, 2023
Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip systemVinny Negi, Dillon Gavlock, Mark T Miedel, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2026
Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platformDillon C Gavlock, Michael W Castiglione, Allen Wang, et al.
Pageof 8